Bioresorbable Scaffolds: Where Do We Stand Now? (Video)
Despite the equivocal results of the ABSORB trials to date, the key question remains what happens over the long term with these devices.
Interest in bioresorbable scaffolds endures despite an excess of adverse outcomes with the Absorb™ bioresorbable scaffold at year 2 of the ABSORB III trial reported at the American College of Cardiology meeting in March (detailed here). In this three-minute video, ABSORB III principal investigator and Cleveland Clinic cardiologist Stephen Ellis, MD, explains why the rationale behind bioresorbable scaffolds remains intact and that the key question is what happens with these devices over the long term.